On August 9, 2019, LGC Standards Canada Limited (“LGC”), a subsidiary of LGC Limited and a portfolio company of KKR & Co. Inc., acquired a majority stake in Toronto Research Chemicals Inc. (“TRC”) and Synfine Research Limited. Financial terms of the investment were not publicly disclosed.
Founded in 1982, TRC is a leading manufacturer and supplier of synthetic organic bio-chemicals which are used as reference standards, research tools and building blocks by a highly diversified global customer base across the pharmaceutical, applied and research sectors.
LGC was represented in-house by Neetu Ogle, General Counsel, Matt Leake, Senior Legal Counsel, and Jeremy Booker, Deputy General Counsel. External representation for LGC was provided by Torkin Manes LLP with a legal team lead by Matthew Tevlin and including Adrian Myers, Daniel Katzin, Nicholas Dempsey (M&A), Leonard Rodness, Kenneth Beallor, Stephanie Eiley (Real Estate), Daniel Pugen, Gillian Howe (Employment), Wesley Isaacs (Tax), Lisa Lifshitz (IT/Privacy), Matt Maurer (Cannabis).
Further external representation was provided to LGC by Victor Krichker of Bereskin & Parr LLP (Intellectual Property), Donna Shier and Gatlin Smeijers of Willms & Shier Environmental Lawyers LLP (Environmental and Chemical Regulatory).
Dentons Canada LLP acted for one of the sellers and TRC with a legal team lead by Laurence Geringer and including Whitney Wakeling, Matthew Dunnet (M&A), Paul Shantz, Sheldon Disenhouse, Rikki Yunger (Real Estate), Mark Jadd, Jessica Fabbro, Paige Donnelly (Tax), Scott Sweatman, Matthew Curtis (Employment) and James Wishart (Cannabis).
Torys LLP acted for the other seller with a legal team led by Matthew Cockburn and including Danielle Traub (M&A) and Andy Gibbons (Real Estate). Further external representation was provided by Brandon Wiener of Thorsteinssons LLP (Tax).